ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

New anti-interferon alpha therapy for lupus nabs $5.8M, could start clinical trials next year

New anti-interferon alpha therapy for lupus nabs $5.8M, could start clinical trials next year

November 1, 2012 10:52 am by | 0 Comments

The approval of Human Genome Sciences/GlaxoSmithKline’s Benlysta last year ended a drought of new drug approvals for the autoimmune disease lupus that had lasted more than half a century.A lengthy ... Read more

Experimental lupus therapy from Argos in partnering talks after strong phase 1

Experimental lupus therapy from Argos in partnering talks after strong phase 1

June 8, 2012 1:24 pm by | 1 Comments

 The experimental lupus treatment being developed by Argos Therapeutics is showing promise in early stage clinical trials, but the questions remain whether it’s enough progress to attract interest from a ... Read more


Lupus flare diagnostic to be developed under LabCorp, XDx partnership

Lupus flare diagnostic to be developed under LabCorp, XDx partnership

May 24, 2012 10:45 am by | 0 Comments

LabCorp (NYSE:LH) is partnering with molecular diagnostics firm XDx to develop a new diagnostic for lupus flares.Burlington, North Carolina-based LabCorp will work with XDx to develop a biomarker and commercialize ... Read more